{"id":29,"date":"2026-05-30T09:53:57","date_gmt":"2026-05-30T09:53:57","guid":{"rendered":"https:\/\/phybiomed-prima.eu\/?page_id=29"},"modified":"2026-10-03T18:24:15","modified_gmt":"2026-10-03T18:24:15","slug":"elementor-29","status":"publish","type":"page","link":"https:\/\/phybiomed-prima.eu\/?page_id=29","title":{"rendered":"Consortium partners"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n
\n \t\t\t


Our Consortium <\/strong>

PHYBIOMED brings together eight partner institutions from six Mediterranean countries: France, Algeria, Morocco, Portugal, Spain and T\u00fcrkiye. Coordinated by INSA Rouen Normandie, the consortium combines complementary expertise in advanced wastewater treatment, microalgal biotechnology, anaerobic digestion, renewable energy, resource recovery, biofertilisers, digital decision-support tools and sustainability assessment.

8 partner institutions \u00b7 6 countries \u00b7 36 months \u00b7 June 2025\u2013June 2028 \u00b7 Approximately \u20ac0.92 million in total eligible project costs
<\/strong>
Funding Framework<\/strong>
PHYBIOMED was selected under the PRIMA Section 2 2024 Multi-topic Call. Under this funding framework, participating research teams are supported through their respective national funding mechanisms.The French, Portuguese, Algerian, Spanish and Turkish teams are supported respectively by the ANR<\/strong>, FCT<\/strong>, DGRSDT<\/strong>, AEI<\/strong> and T\u00dcB\u0130TAK<\/strong>. Mohammed First University participates with its own funding.National grant amounts may differ from total eligible project costs according to the funding rules applicable in each participating country.<\/p>\n\t\t\n<\/div>\n\t\t\t\"\"\/\t\t\n<\/div>\n

\n
\n \t\t
\n\t\t\t\t\t\t\t\t\t

\u00a0<\/span><\/p>

PHYBIOMED benefits from the active involvement of associate partners and stakeholders<\/strong> who provide complementary expertise, facilitate knowledge transfer, and support the validation of project solutions under real operational conditions. Their contribution strengthens the project’s scientific excellence, practical relevance, and long-term impact across the Mediterranean region.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\n<\/div>\n\t\t\t\"\"\/\t\t\n<\/div>\n

\n \t\t
\n\t\t\t\t\t\t\t\t\t

\u00a0<\/p>

\u00a0<\/p>

Associate Partner \u2013 Dr. Salma Latique (Morocco)<\/span><\/h3>

University Sidi Mohamed Ben Abdellah, Fez<\/strong><\/p>

Dr. Salma Latique is an expert in microalgae cultivation, algal biotechnology, and biomass valorization. Her research focuses on the selection, optimization, and cultivation of microalgal strains for environmental and biotechnological applications. Within PHYBIOMED, she will support the consortium in identifying the most suitable microalgal strains for wastewater treatment, nutrient recovery, CO\u2082 capture, and bio-based product generation. Her expertise will contribute to improving the performance and robustness of the microalgae-based processes developed in the project.<\/p>

Associate Partner \u2013 Dr. Amina Benaissa (Algeria)<\/span><\/h3>

University of Skikda<\/strong><\/p>

Dr. Amina Benaissa is a specialist in wastewater treatment and environmental process engineering. Her research activities focus particularly on adsorption processes, electrocoagulation technologies, water quality assessment, and environmental impact evaluation. Within PHYBIOMED, she will contribute her expertise to the development, optimization, and evaluation of innovative wastewater treatment processes, especially those based on adsorption and electrochemical technologies.<\/p>

Stakeholder \u2013 SEACO (Algeria)<\/span><\/h3>

Water Distribution and Drinking Water Utility<\/strong><\/p>

SEACO (Soci\u00e9t\u00e9 de l’Eau et de l’Assainissement de Constantine) is responsible for drinking water distribution and water services in the Constantine region. As a PHYBIOMED stakeholder, SEACO is particularly interested in innovative technologies for water treatment, wastewater reclamation, and the production of safe drinking water. The company will benefit from the project’s developments in advanced water treatment processes, including photocatalysis, electrocoagulation, adsorption, and electrochemical technologies, while providing valuable feedback regarding their applicability under real operating conditions.<\/p>

Stakeholder \u2013 EGEZIA (Algeria)<\/span><\/h3>

Management of Ain-Smara Industrial Zone<\/strong><\/p>

EGEZIA is a subsidiary of the ENMTP Group responsible for the management of the Ain-Smara Industrial Zone. Its activities include potable water distribution, wastewater treatment, operation of a wastewater treatment plant, and maintenance of water, electricity, and gas distribution networks. As a PHYBIOMED stakeholder, EGEZIA will facilitate access to real wastewater samples and operational data for testing and validating the technologies developed within the project. EGEZIA is particularly interested in innovative treatment solutions, energy-efficient processes, resource recovery, and CHP-based energy valorization scenarios: https:\/\/www.enmtp.dz\/filiale-de-services-egezia-2\/<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\n<\/div>\n

\n
\n \t\t
\n\t\t\t\t\t\t\t\t\t

\n<\/p>

The CV of all partners<\/strong><\/span><\/p>\n

\n<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\n<\/div>\n\n<\/div>\n

\n \t\t
\n\t\t\t\t\t\t\t\t\t

Coordinator Institution: INSA Rouen Normandie (France)
Dr. Lokmane Abdelouahed
<\/strong>Email: lokmane.abdelouahed@insa-rouen.fr<\/strong>
Website: lokmane-abdelouahed.lokmane21200490174.chatgpt.site<\/a><\/p>

\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\n<\/div>\n

\n \t\t\t\"\"\/\t\t\n<\/div>\n
\n \t\t
\n\t\t\t\t\t\t\t\t\t

Partner Institution: University of Porto (Portugal)<\/strong><\/p>

Dr. Jos\u00e9 Carlos Magalhaes<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t

\n \n<\/div>\n\n<\/div>\n
\n \t\t\t\"\"\/\t\t\n<\/div>\n
\n \t\t
\n\t\t\t\t\t\t\t\t\t

Partner Institution: \u00c9cole Nationale Polytechnique Constantine\u00a0(Algeria)<\/strong><\/p>

Dr. Zineb Boutamine<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\n<\/div>\n

\n \t\t\t\"\"\/\t\t\n<\/div>\n
\n \t\t
\n\t\t\t\t\t\t\t\t\t

Partner Institution: \u0130stanbul \u00dcniversitesi – Cerrahpa\u015fa (Turkey)<\/strong><\/p>

Prof. Dr. Sezar Gulbaz<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\"\"\/\t\t\n<\/div>\n

\n \t\t\t\"\"\/\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Partner Institution:\u00a0<\/strong>University of Le\u00f3n\u00a0 (Spain)<\/strong><\/p>

Dr. Pen\u00e9lope Garcia-Angulo<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\"\"\/\t\t\n<\/div>\n

\n \n<\/div>\n\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Our Consortium PHYBIOMED brings together eight partner institutions from six Mediterranean countries: France, Algeria, Morocco, Portugal, Spain and T\u00fcrkiye. Coordinated by…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-29","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/phybiomed-prima.eu\/index.php?rest_route=\/wp\/v2\/pages\/29","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/phybiomed-prima.eu\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/phybiomed-prima.eu\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/phybiomed-prima.eu\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/phybiomed-prima.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=29"}],"version-history":[{"count":86,"href":"https:\/\/phybiomed-prima.eu\/index.php?rest_route=\/wp\/v2\/pages\/29\/revisions"}],"predecessor-version":[{"id":1382,"href":"https:\/\/phybiomed-prima.eu\/index.php?rest_route=\/wp\/v2\/pages\/29\/revisions\/1382"}],"wp:attachment":[{"href":"https:\/\/phybiomed-prima.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=29"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}